Michael Parini is the founder of Spur Therapeutics. Spur Therapeutics has raised $274M in total funding. Based in Boston, MA.
Michael Parini is the CEO of Spur Therapeutics, a clinical-stage biotechnology company focused on developing AAV gene therapies for chronic diseases like Gaucher disease. He has a background in genetic medicines, having previously led significant capital raises.
Full founder directory · Investor directory · Company funding database · Fundraising library